高血圧患者の治療結果を改善する薬剤師主導のデジタル医療介入 - 体系的レビュー
Geraldo Surya1, Angelica1, Widya Norma Insani1,2
1Department of Pharmacology and Clinical Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
Journal of multidisciplinary healthcare
|September 3, 2025
まとめ
薬剤師主導のデジタルヘルスの介入は,高血圧の管理を改善し,薬の服用率を高めることを約束しています. さまざまな医療環境における有効性を確認するには,さらなる研究が必要です.
科学分野:
- デジタル・ヘルス
- 心血管医学
- 薬剤のケア
背景:
- デジタル・ヘルス・インターベンション (DHI) は 高血圧のような慢性疾患の管理に 重要な戦略として 登場しています
- 薬剤師が主導するDHIは 薬の管理における専門知識を活用して 患者のケアにユニークなアプローチを提供します
研究 の 目的:
- 高血圧管理のための薬剤師主導の DHIを評価するランダム化対照試験 (RCT) を体系的にレビューする.
- 血圧の低下,薬の服用,薬物関連の問題に対する DHI の影響を評価する.
主な方法:
- 1996年12月から2024年5月まで公表されたRCTの体系的なレビューは,PubMedで特定されました.
- 含まれている研究は,通常のケアと比較して,電話,ウェブ,またはモバイルベースの薬剤師主導のDHIに焦点を当てた.
- PRISMAのガイドラインに従って分析されたRCTは14件含まれていた.
主要な成果:
- 8つの研究で (57. 14%) 介入グループで有意な血圧低下が示されました.
- 治療の順守を評価した5つの研究ではすべて改善が報告されました.
- ある研究では,薬物関連の問題の特定が強化されたことが示された.
結論:
- 薬剤師主導のDHIは,血圧のコントロールとアデレンスを含む高血圧のアウトカムを改善する可能性があります.
- 介入の有効性は,頻度,パーソナライゼーション,患者の関与などの要因に影響されます.
- 多様なグローバル環境や医療システムで DHIを検証するにはさらなる研究が必要である.
関連する概念動画
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
37
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
37
01:23Hypertension V: Nursing Management
42
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
42
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
01:25Errors occurring during blood pressure monitoring
964
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
964
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23